Work is frequently perceived as a risk factor rather than a source of well-being, life values, development, and health. A special issue of Work on work-related pain in collaboration with the Journal of Back and Musculoskeletal ...
Jul 11, 2024
0
0
A multicenter safety study at UC Davis Health tested a protein drug (INBRX-101), developed to improve care for people with alpha-1 antitrypsin deficiency (AATD), and showed the therapy is quite safe.
Jul 11, 2024
0
17
Just 15 minutes a week spent writing about how we have successfully coped with difficult situations could help make us more resilient, Macquarie University psychology researchers have found.
Jul 11, 2024
0
0
Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from the National Institutes of Health ...
Jul 11, 2024
0
31
A clinical trial has shown that a new drug combination utilized before surgery completely eliminated or shrunk melanoma tumors in 70% of trial participants. The phase II clinical trial, NeoACTIVATE, enrolled patients with ...
Jul 11, 2024
0
54
Nirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a study published in the July 11 issue of the New England ...
Jul 11, 2024
0
0
A major clinical trial, led by researchers at the University of Nottingham, has shown the Lee Silverman Voice Treatment (LSVT LOUD) is more effective than the current speech and language therapy provided by the NHS, when ...
Jul 10, 2024
0
19
Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time. Today, triple combination therapy ...
Jul 10, 2024
0
0
Adeno-associated virus (AAV)-based viral vectors used in human gene therapy can trigger innate immune pathways, leading to the initiation of adaptive immune responses. A new review article published in the journal Human Gene ...
Jul 10, 2024
0
0
Researchers from Queen Mary University London and Emory University used a novel AI-based analytic tool to better understand how tumor infiltrating lymphocytes (TILs) can predict which cases of Ductal Carcinoma in Situ (DCIS) ...
Jul 10, 2024
0
8
